Artificial intelligence (AI) will remain a central theme in education for 2026. K-12 institutions are prioritizing instructional applications, while higher education is seeing broader adoption across both academics and operations. In this video, Jitin Sethi discusses the evolving role of AI across the education value chain.

The renaissance of healthcare logistics

Healthcare logistics sits at the intersection of three durable forces: structural healthcare demand, rising therapy complexity and rapid digital enablement. Regulatory intensity, specialized infrastructure and high consequence of failure create defensible barriers to entry, while fragmentation creates consolidation opportunity and AI creates disruptive growth and value creation potential.

For strategics, the imperative is capability acquisition before valuation multiples and competitive intensity rise further. For private equity, healthcare logistics offers recurring revenue, margin durability and clear buy-and-build pathways. For founders, the market presents a generational opportunity to institutionalize and scale highly attractive, mission-critical businesses.

As healthcare logistics becomes not merely a delivery mechanism but a determinant of clinical success, the segment should be on the radar for strategics and investors across the ecosystem.

The next phase of value creation will be defined by those who recognize this shift and act on it decisively.

Healthcare logistics at an inflection point

Healthcare represents approximately 10% of global gross domestic product with spending growing at 5%-plus annually in many markets. It has long attracted investment due to its structural resilience, regulatory barriers and persistent inefficiencies. As urgency from the ballooning costs of an aging global population is paired with technological advances, many segments of the healthcare market are seeing significant investment and transformation. Historically, healthcare logistics has been relatively overlooked by investors, but no longer.

The healthcare supply chain is an extremely demanding logistics environment. Precision, compliance and speed are nonnegotiable. Billions of dollars in life-critical products move daily across manufacturers, distributors, 3PLs (third-party logistics providers), freight forwarders and last-mile specialists, under strict service levels and regulatory oversight. A variety of factors have accelerated the need for maturation of the healthcare logistics ecosystem, including supply chain shocks from COVID-19; ongoing geopolitical volatility; margin pressure in pharmaceuticals, medical devises and diagnostics manufacturers; and the consolidation of healthcare providers into larger, more sophisticated customers.

Furthermore, technology advances are unlocking new operating models to transform logistics from an asset-heavy service function into a data-driven, insight-led platform opportunity. Consequently, what was once viewed as a niche extension of general freight is increasingly recognized as a high-margin, defensible and strategically critical vertical.

This report is one of three total pieces co-authored by L.E.K. Consulting and Lincoln International, delves into why we believe the market is witnessing an inflection point in the evolution of the healthcare logistics market, which provides a unique opportunity for investment.

A mapping of the healthcare logistics ecosystem

Healthcare logistics is not a single market but rather an interconnected set of market sub-segments with specialized operators managing the flow of products and information between manufacturers and providers (see Figures 1 and 2).

Upstream, pharmaceutical, medical device and diagnostics manufacturers produce a wide variety of products under tightly regulated quality systems and a distributed global manufacturing footprint. Their labeling, serialization, temperature and service-level requirements cascade downstream, shaping the operational burden for all logistics partners.

Large broadline logistics providers, such as UPS, FedEx and DHL, play a critical role in moving bulk and parcel volumes from manufacturing plants and distribution centers to distributors and providers. Their value proposition centers on balancing speed, cost and temperature integrity at scale, often leveraging global networks and standardized operating models.

Distributors — both broadline and specialty — aggregate supply, manage inventory, provide last-mile replenishment and provide a growing list of supply chain services to hospitals, labs and nonacute sites of care. They act as buffers during shortages and differentiate through fill rates, cold-chain reliability, and integration into provider procurement and track-and-trace systems. In addition, distributors have increasingly begun to sell their own self-manufactured or private-label products, especially in the medical devices segment. Distributors may work with repackagers like Safecor that take devices or medicines from manufacturers and repackage them to meet customer needs (e.g., unit dose prescriptions).

A growing layer of cold-chain specialists supports temperature-sensitive therapies through validated packaging, cryogenic handling, sensors and real-time condition monitoring. As biologics, cell and gene therapies, and personalized medicine expand, these capabilities are moving from premium add-ons to mission-critical infrastructure.

On the reverse-flow side of the ecosystem, device reprocessors collect eligible single-use devices, reprocess and/or repair them to approved standards, and return them to use, reducing waste and total cost of care. Their operating models depend on reliable reverse logistics, documented chain of custody, and consistent provider adherence to segregation and collection protocols.

Healthcare-specialized 3PLs and couriers focus on orchestration rather than scale, managing warehousing, cross-dock operations and temperature-controlled last-mile delivery, including STAT, OR-direct and specimen movements. These providers win business based on standard operating procedure discipline, validated equipment, auditable chain of custody and time-definite performance for clinically critical moves.

A distinct but closely related role is played by freight forwarders, particularly for international product flows. These players coordinate cross-border transportation across air, ocean and ground, managing carrier selection, customs clearance, trade compliance and hand-offs across jurisdictions. In healthcare, forwarders differentiate through validated lane management, temperature-controlled air freight capabilities, regulatory expertise and the ability to dynamically reroute shipments during disruptions. These capabilities have become increasingly valuable amid geopolitical volatility and capacity constraints.

Finally, a set of reverse logistics and waste management providers handles returns, recalls, refurbishment, and compliant destruction of regulated or hazardous. These services create value by accelerating credit and replacement cycles, minimizing write-offs, and maintaining rigorous regulatory documentation — capabilities that providers prioritize for risk control and audit readiness.

Overlaying the physical logistics network is a growing layer of software and data platforms that support planning, visibility and execution across the healthcare supply chain. Technology-enabled players such as Altana, Flexport and other logistics software providers aggregate data across shippers, carriers and geographies to improve end-to-end visibility and predict disruptions. In healthcare-specific applications, these platforms are increasingly tailored to regulated workflows, incorporating serialization data, temperature and condition monitoring, and compliance documentation. Their asset-light, data-centric models offer scalable growth potential and the opportunity to become system-of-record or system-of-insight layers across a fragmented logistics ecosystem.

Overlaying the physical network is an increasingly important digital layer: logistics software, data visibility platforms and AI-enabled orchestration tools. These asset-light players aggregate data across shippers and carriers, predict disruptions, and enable proactive intervention. As fragmentation persists across the ecosystem, these platforms are well positioned to become system-of-record or system-of-insight layers.

The result is a fragmented but high-barrier ecosystem where specialization, compliance credibility and data integration drive competitive advantage.

For more information, please contact us.

L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2026 L.E.K. Consulting LLC

As Higher Education faces mounting changes from demographic shifts, changing workforce needs and the growth of alternative credentials, leadership priorities have become increasingly clear: attract students and support them through graduation. This video explores how these dynamics are redefining institutional priorities and driving changes in budget strategy.

L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2026 L.E.K. Consulting LLC

Student mental health and well-being, teacher recruitment and retention, and academic outcomes are growing focus areas for K-12 district leaders. In this video, Laura Brookhiser explores how district leaders across the U.S. are prioritizing their spend, and how shifting priorities are influencing investment decisions.

For more insights into K-12 priorities, read our report here.

L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2026 L.E.K. Consulting LLC

AI is rapidly moving from experimentation to a source of real competitive advantage in healthcare. While early applications have focused on efficiency and productivity, the opportunity now extends across the entire patient journey – from diagnostics and triage through to clinical decision support and proactive health management.

In this discussion, we explore how organisations can capture this “AI delta,” the growing gap in value between those effectively deploying AI and those that are not. We also highlight the common barriers – from fragmented, bottom-up innovation to uncertainty around investment – and why a leadership-led, portfolio-based approach is critical to unlocking sustained impact.

L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2026 L.E.K. Consulting LLC